Recent Updates
Recently added Catalysts
IMTX

Immatics Appoints Alise Reicin to Board of Directors

Key Takeaway: Immatics Appoints Alise Reicin to Board of Directors
Price reaction · baseline $11.88 (2024-07-30 close) · hit after-hours · clean, no other IMTX news in the window
day 0 close
+1.2%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Lead asset
IMA401
Phase 1 · Refractory Cancer

Full Press Release Details

Immatics Appoints Alise Reicin to Board of Directors.
Last updated: Jul 31, 2024